LINC00364: A Potential Drug Target and Biomarker (G100874145)

Target Name: LINC00364

NCBI ID: G100874145

LINC00364

Other Name(s): long intergenic non-protein coding RNA 364 | LncRNA00364 | Long intergenic non-protein coding RNA 364

LINC00364: A Potential Drug Target and Biomarker

LINC00364 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LINCRNA family, which is known for their role in regulating gene expression and cell signaling. LINC00364 has been shown to play a role in a variety of physiological processes, including cell survival, proliferation, and migration. As a result, it has potential as a drug target or biomarker.

One of the key features of LINC00364 is its ability to interact with various signaling pathways. It has been shown to play a role in the PI3K/Akt signaling pathway, which is involved in a wide range of cellular processes, including cell survival, angiogenesis, and inflammation. Additionally, LINC00364 has been shown to interact with the TGF-β pathway, which is involved in cell growth, differentiation, and repair.

These interactions make LINC00364 a promising candidate for drug targeting. By modulating the activity of these signaling pathways, LINC00364 could be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Another potential use of LINC00364 as a drug target is its ability to serve as a biomarker. Its expression has been shown to be regulated in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and chronic obstructive pulmonary disease (COPD). By using LINC00364 as a biomarker, researchers could monitor the effectiveness of different treatments and determine whether treatment is leading to changes in the expression of this protein.

In addition to its potential as a drug target or biomarker, LINC00364 also has potential as a research tool. Its expression has been shown to be regulated in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and COPD. This makes it a useful tool for studying the effects of different treatments on these conditions.

Overall, LINC00364 is a promising candidate for drug targeting and biomarker research. Its ability to interact with multiple signaling pathways and its expression in a variety of tissues make it a valuable tool for the study of disease. Further research is needed to fully understand its potential and to determine its utility as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 364

The "LINC00364 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00364 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets